| Literature DB >> 29914427 |
Yongho Jee1, Youngwon Kim2,3, Sun Ha Jee4, Mikyung Ryu5,6.
Abstract
BACKGROUND: Little is known about longitudinal associations of exercise with different types of cancer, particularly in Asian populations. The purpose of this research was to estimate the association between the duration of exercise and all-cause and cancer-specific mortality.Entities:
Keywords: Exercise; cancer; cohort; death
Mesh:
Year: 2018 PMID: 29914427 PMCID: PMC6006742 DOI: 10.1186/s12889-018-5669-1
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Baseline Characteristics of the Korean Metabolic Syndrome Mortality Study
| No exercise | Exercise | Total duration of exercise per week (minutes/week)a | |||
|---|---|---|---|---|---|
| <150 | 150-299 | ≥300 | |||
| (N=162,863) | (N=140,565) | (N=47,579) | (33,729) | (29,102) | |
| Age, y, mean (SD) | 44.7 (11.2) | 47.7 (10.3) | 46.1 (10.0) | 47.6 (10.2) | 49.7 (10.3) |
| Body mass index, kg/m2, mean (SD) | 23.5 (3.2) | 24.0 (2.8) | 23.7 (2.9) | 23.8 (2.8) | 23.9 (2.7) |
| Alcohol drinking, g /day | 12.3 (27.2) | 13.8 (26.8) | 14.0 (26.2) | 13.1 (26.2) | 14.0 (28.4) |
| Average frequency per week | 0 | 3.2 (2.0) | 2.1 (1.5) | 3.6 (1.6) | 4.8 (1.8) |
| Average minutes per exercise (minutes) | 0 | 74.4 (65.0) | 48.0 (40.8) | 76.2 (60.7) | 119.7 (81.6) |
| Total duration of exercise (minutes/week) | 0 | 218.3 (202.0)a | 74.8 (37.8) | 203.0 (35.6) | 469.0 (219.9) |
| Condition, % | |||||
| Sex (male) | 51.6 | 62.3 | 66.4 | 59.2 | 59.3 |
| Alcohol drinking (yes) | 59.2 | 68.4 | 71.4 | 66.2 | 65.6 |
| Smoking status (former) | 12.7 | 23.1 | 22.0 | 23.3 | 25.7 |
| Smoking status (current) | 34.0 | 29.3 | 32.7 | 26.2 | 25.7 |
a30,155 with missing
Age-adjusted Mortality Rates per 100,000 and Hazard Ratios (HR) for Death Due to All Causes, All Cancers, and Various Cancers by total duration (minutes/week) of Exercise per Week at Baseline in Korean men, 1994-2015
| No exercise | Exercise | Total duration of exercise per week (minutes/week) | P for linear trend | |||
|---|---|---|---|---|---|---|
| <150 | 150-299 | ≥300 | ||||
| All causes | ||||||
| Number of death | 6,150 | 5,769 | 1,668 | 1,215 | 1,355 | |
| Death rate | 572.7 | 389.3 | 371.7 | 376.8 | 384.2 | |
| HR (95% CI) | 1.0 | 0.70 (0.68 – 0.73) | 0.69 (0.65-0.73) | 0.67 (0.63-0.71) | 0.67 (0.63-0.71) | <.0001 |
| All cancers | ||||||
| Number of death | 2,739 | 2,740 | 781 | 611 | 640 | |
| Death rate | 233.2 | 166.4 | 150.5 | 165.5 | 163.3 | |
| HR (95% CI) | 1.0 | 0.77 (0.73 – 0.81) | 0.74 (0.68-0.80) | 0.78 (0.71-0.85) | 0.73 (0.67-0.80) | <.0001 |
| Esophagus | ||||||
| Number of death | 65 | 56 | 16 | 15 | 13 | |
| Death rate | 5.6 | 3.2 | 4.0 | 4.1 | 2.7 | |
| HR (95% CI) | 1.0 | 0.67 (0.47 – 0.97) | 0.64 (0.37-1.12) | 0.84 (0.48-1.48) | 0.66 (0.36-1.21) | 0.1426 |
| Head and Neck | ||||||
| Number of death | 37 | 32 | 14 | 3 | 7 | |
| Death rate | 3.0 | 1.7 | 2.2 | 0.7 | 1.3 | |
| HR (95% CI) | 1.0 | 0.67 (0.41 – 1.09) | 0.98 (0.53-1.83) | 0.28 (0.09-0.93) | 0.60 (0.26-1.36) | 0.0595 |
| Liver | ||||||
| Number of death | 551 | 573 | 163 | 130 | 132 | |
| Death rate | 40.5 | 31.0 | 26.4 | 34.3 | 29.1 | |
| HR (95% CI) | 1.0 | 0.83 (0.74 – 0.94) | 0.76 (0.64-0.90) | 0.85 (0.70-1.03) | 0.83 (0.68-1.00) | 0.0183 |
| Lung | ||||||
| Number of death | 745 | 650 | 173 | 128 | 171 | |
| Death rate | 70.7 | 39.2 | 33.2 | 36.0 | 42.6 | |
| HR (95% CI) | 1.0 | 0.71 (0.64 – 0.79) | 0.65 (0.55-0.77) | 0.64 (0.53-0.77) | 0.75 (0.63-0.89) | <.0001 |
| Colorectal | ||||||
| Number of death | 203 | 185 | 60 | 42 | 39 | |
| Death rate | 17.0 | 11.6 | 10.3 | 12.1 | 9.7 | |
| HR (95% CI) | 1.0 | 0.65 (0.53 – 0.80) | 0.72 (0.54-0.96) | 0.66 (0.47-0.92) | 0.55 (0.39-0.78) | 0.0001 |
| Pancreas | ||||||
| Number of death | 172 | 252 | 73 | 69 | 50 | |
| Death rate | 13.7 | 14.5 | 14.4 | 17.1 | 11.5 | |
| HR (95% CI) | 1.0 | 1.0 (1.00 – 1.00) | 1.11 (0.84-1.46) | 1.44 (1.08-1.90) | 0.96 (0.69-1.32) | 0.3910 |
| Kidney | ||||||
| Number of death | 31 | 42 | 12 | 9 | 11 | |
| Death rate | 2.3 | 3.3 | 2.0 | 3.1 | 7.0 | |
| HR (95% CI) | 1.0 | 0.95 (0.59 – 1.53) | 0.93 (0.47-1.81) | 0.92 (0.44-1.95) | 1.01 (0.50-2.04) | 0.9846 |
| Stomach | ||||||
| Number of death | 347 | 287 | 89 | 63 | 64 | |
| Death rate | 31.8 | 17.9 | 18.6 | 15.3 | 16.1 | |
| HR (95% CI) | 1.0 | 0.62 (0.53 – 0.73) | 0.65 (0.52-0.83) | 0.62 (0.47-0.81) | 0.56 (0.43-0.74) | <.0001 |
| Prostate | ||||||
| Number of death | 64 | 84 | 22 | 20 | 21 | |
| Death rate | 7.0 | 6.6 | 5.8 | 6.7 | 6.1 | |
| HR (95% CI) | 1.0 | 0.80 (0.57 – 1.11) | 0.80 (0.49-1.31) | 0.85 (0.51-1.41) | 0.72 (0.44-1.19) | 0.1641 |
Adjusted for age, alcohol drinking status (non, and current), and smoking status (never, former, and current)
Age-adjusted Mortality Rates per 100,000 and Hazard Ratios (HR) for Death Due to All Causes, All Cancers, and Various Cancers by total duration (minutes/week) of Exercise per Week at Baseline in Korean women, 1994-2015
| No exercise | Exercise | Total duration of exercise per week (minutes/week) | P for linear trend | |||
|---|---|---|---|---|---|---|
| <150 | 150-299 | ≥300 | ||||
| All causes | ||||||
| Number of death | 3,345 | 1,619 | 472 | 367 | 356 | |
| Death rate | 267.9 | 242.3 | 240.4 | 220.9 | 231.2 | |
| HR (95% CI) | 1.0 | 0.71 (0.67 – 0.75) | 0.73 (0.66-0.80) | 0.65 (0.58-0.72) | 0.69 (0.61-0.76) | <.0001 |
| All cancers | ||||||
| Number of death | 1,320 | 740 | 201 | 174 | 156 | |
| Death rate | 86.2 | 92.6 | 93.9 | 88.2 | 84.5 | |
| HR (95% CI) | 1.0 | 0.81 (0.74 – 0.89) | 0.78 (0.67-0.90) | 0.76 (0.65-0.89) | 0.75 (0.63-0.88) | <.0001 |
| Esophagus | ||||||
| Number of death | 3 | 2 | 0 | 1 | 0 | |
| Death rate | 0.6 | 0.2 | ||||
| HR (95% CI) | 1.0 | 0.83 (0.14 – 5.07) | NE | NE | NE | NE |
| Head and Neck | ||||||
| Number of death | 9 | 8 | 2 | 2 | 0 | |
| Death rate | 0.9 | 1.7 | ||||
| HR (95% CI) | 1.0 | 1.26 (0.48 – 3.28) | NE | NE | NE | NE |
| Liver | ||||||
| Number of death | 152 | 95 | 28 | 18 | 25 | |
| Death rate | 8.5 | 12.7 | 17.2 | 6.1 | 14.4 | |
| HR (95% CI) | 1.0 | 0.90 (0.70 – 1.17) | 0.94 (0.63-1.41) | 0.69 (0.42-1.12) | 1.04 (0.68-1.59) | 0.5412 |
| Lung | ||||||
| Number of death | 242 | 120 | 35 | 28 | 20 | |
| Death rate | 16.4 | 15.2 | 15.2 | 13.8 | 10.2 | |
| HR (95% CI) | 1.0 | 0.74 (0.59 – 0.92) | 0.76 (0.53-1.08) | 0.69 (0.47-1.02) | 0.54 (0.34-0.85) | 0.0013 |
| Colorectal | ||||||
| Number of death | 137 | 79 | 19 | 22 | 13 | |
| Death rate | 9.3 | 8.9 | 8.5 | 8.4 | 7.4 | |
| HR (95% CI) | 1.0 | 0.83 (0.63 – 1.10) | 0.71 (0.44-1.14) | 0.92 (0.59-1.45) | 0.60 (0.34-1.05) | 0.0801 |
| Pancreas | ||||||
| Number of death | 119 | 75 | 22 | 15 | 20 | |
| Death rate | 6.8 | 7.4 | 7.6 | 5.5 | 9.6 | |
| HR (95% CI) | 1.0 | 0.91 (0.68 – 1.21) | 0.94 (0.60-1.49) | 0.73 (0.47-0.81) | 1.06 (0.66-1.71) | 0.7405 |
| Kidney | ||||||
| Number of death | 7 | 3 | 0 | 0 | 1 | |
| Death rate | 0.2 | 0.3 | 0.0 | 0.0 | 0.5 | |
| HR (95% CI) | 1.0 | 0.51 (0.13 – 1.98) | NE | NE | NE | NE |
| Stomach | ||||||
| Number of death | 143 | 62 | 13 | 17 | 12 | |
| Death rate | 11.7 | 8.2 | 7.3 | 9.1 | 6.8 | |
| HR (95% CI) | 1.0 | 0.62 (0.46 – 0.83) | 1.30 (0.80-2.12) | 0.82 (0.44-1.55) | 0.93 (0.50-1.76) | 0.0036 |
| Breast | ||||||
| Number of death | 79 | 56 | 20 | 11 | 11 | |
| Death rate | 6.1 | 6.4 | 8.3 | 4.2 | 6.6 | |
| HR (95% CI) | 1.0 | 1.06 (0.75 – 1.50) | 0.65 (0.52-0.83) | 0.62 (0.47-0.81) | 0.56 (0.43-0.74) | 0.7654 |
| Cervix | ||||||
| Number of death | 26 | 14 | 4 | 2 | 2 | |
| Death rate | 1.3 | 2.6 | 1.6 | 2.1 | 0.7 | |
| HR (95% CI) | 1.0 | 0.74 (0.39 – 1.42) | 0.74 (0.26-2.13) | 0.42 (0.10-1.78) | 0.46 (0.11-1.95) | 0.1234 |
Adjusted for age, alcohol drinking status (non, and current), and smoking status (never, former, and current)
Age-adjusted Mortality Rates per 100,000 and Hazard Ratios (HR) for Death Due to All Causes, All Cancers, and Various Cancers by total duration (minutes/week) of Exercise per Week at Baseline in Korean men and women, 1994-2015
| No exercise | Total duration of exercise per week (minutes/week) | P for linear trend | ||||
|---|---|---|---|---|---|---|
| <100 | 100 - 249 | 250 - 399 | ≥400 | |||
| Men | ||||||
| All causes | ||||||
| Number of death | 6,150 | 1,162 | 1,562 | 644 | 870 | |
| Death rate | 572.7 | 383.4 | 370.5 | 370.7 | 391.8 | |
| HR (95% CI) | 1.0 | 0.71 (0.67 – 0.76) | 0.66 (0.63 – 0.70) | 0.65 (0.60 – 0.71) | 0.69 (0.64 – 0.74) | <.0001 |
| All cancers | ||||||
| Number of death | 2,739 | 547 | 767 | 302 | 416 | |
| Death rate | 233.2 | 158.4 | 159.4 | 142.6 | 179.9 | |
| HR (95% CI) | 1.0 | 0.76 (0.70 – 0.84) | 0.75 (0.70 – 0.81) | 0.71 (0.63 – 0.80) | 0.77 (0.70 – 0.85) | <.0001 |
| Women | ||||||
| All causes | ||||||
| Number of death | 3,346 | 317 | 498 | 173 | 212 | |
| Death rate | 267.9 | 220.5 | 242.9 | 207.5 | 235.9 | |
| HR (95% CI) | 1.0 | 0.73 (0.65 – 0.82) | 0.69 (0.63 – 0.76) | 0.60 (0.51 – 0.69) | 0.73 (0.63 – 0.84) | <.0001 |
| All cancers | ||||||
| Number of death | 1,320 | 139 | 223 | 82 | 87 | |
| Death rate | 86.2 | 94.1 | 90.3 | 82.9 | 86.4 | |
| HR (95% CI) | 1.0 | 0.79 (0.67 – 0.94) | 0.78 (0.68 – 0.90) | 0.69 (0.55 – 0.87) | 0.76 (0.61 – 0.94) | 0.0046 |
Fig. 1Hazard ratios and 95% group specific confidence intervals of all causes and all cancer mortality, the Korean Metabolic Syndrome Mortality Study